Fig. 2: ABCC5 expression in prostate cancer patients. | Cell Death Discovery

Fig. 2: ABCC5 expression in prostate cancer patients.

From: Non-drug efflux function of ABCC5 promotes enzalutamide resistance in castration-resistant prostate cancer via upregulation of P65/AR-V7

Fig. 2: ABCC5 expression in prostate cancer patients.The alternative text for this image may have been generated using AI.

A Representative tissue staining images of ABCC5 expression in BPH and tumor tissues with several Gleason scores. Scale bars, 20 μm. B Immunofluorescence images of AR and ABCC5 localization in CRPC tissue. Scale bars, 20 μm. C PCa cells were subjected to the levels of selected proteins. D mRNA levels of AR and ABCC5 were measured by qRT-PCR. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. P, parental cell; R, enzalutamide-resistant cell.

Back to article page